Hormel Sees Limited Earnings Impact From Turkey Business Sale

Core Viewpoint - Hormel is divesting its whole-bird turkey business, which is expected to reduce annual net sales by approximately $50 million, with minimal impact on net income [1] Group 1: Divestiture Details - The divestiture involves the sale of Hormel's whole-bird turkey business to Life-Science Innovations, with financial terms undisclosed [1] - The transaction is anticipated to close in the second quarter of Hormel's current fiscal year [1] - The divestiture aligns with Hormel's strategy to focus on protein offerings, while the Jennie-O ground turkey brand remains a strategic component of the portfolio [3] Group 2: Financial Performance - Hormel's company-wide net sales rose 1.3% to $3.03 billion, slightly below Wall Street expectations of $3.07 billion [5] - Adjusted earnings per share were $0.35, unchanged from the previous year and above Bloomberg consensus estimates of $0.32 [5] Group 3: Market Challenges - Hormel has faced pressure from rising raw material and logistics costs, affecting profitability in its core retail segment [4] - A bird flu outbreak disrupted poultry supply chains last year, and U.S. tariffs on Brazil contributed to higher beef prices [4] - In response to these cost pressures, Hormel, along with competitor Tyson Foods, implemented price increases on select products [4]